Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433)
Abstract Targeted delivery of drugs to the brain is challenging due to the restricted permeability across the blood brain barrier (BBB). Gliomas are devastating cancers and their positive treatment outcome using Temozolomide (TMZ) is limited due to its short plasma half-life, systemic toxicity and l...
Guardado en:
Autores principales: | Sonali Kumari, Saad M. Ahsan, Jerald M. Kumar, Anand K. Kondapi, Nalam M. Rao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/183749ab737e48c48f272de1318a8a76 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy
por: Zhang J, et al.
Publicado: (2018) -
Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma
por: Shi H, et al.
Publicado: (2020) -
Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH
por: Jyotsna U. Rao, et al.
Publicado: (2017) -
Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment
por: Peng Y, et al.
Publicado: (2018) -
Temozolomide is additive with cytotoxic effect of irradiation in canine glioma cell lines
por: Nina Simona Tresch, et al.
Publicado: (2021)